好色先生

好色先生

Explore the latest content from across our publications

Log In

Forgot Password?
Create New Account

Loading... please wait

Abstract Details

Bridging Therapy Triumphs? Meta-analysis Shows IVT+EVT Outperforms EVT Alone in Tandem Occlusions
Cerebrovascular Disease and Interventional Neurology
P6 - Poster Session 6 (5:00 PM-6:00 PM)
4-007
To evaluate whether intravenous thrombolysis (IVT) combined with endovascular therapy (EVT) improves outcomes compared to EVT alone in patients with tandem occlusions.

Tandem lesions, involving simultaneous extracranial and intracranial occlusions, present therapeutic challenges in acute ischemic stroke. The benefit of bridging therapy (IVT+EVT) over EVT alone remains debated.

A systematic review and meta-analysis of PubMed-indexed studies was performed. Binary outcomes were pooled using the Mantel–Haenszel method under a random-effects model (DerSimonian–Laird). Effect sizes were expressed as odds ratios (OR) with 95% confidence intervals (CI). Heterogeneity was assessed with I² and Cochran’s Q. Publication bias was evaluated using Egger’s and Begg’s tests, and trim-and-fill analysis.

Twenty-one studies were included. For functional independence (90-day mRS 0–2), IVT+EVT significantly improved outcomes compared to EVT alone (fixed-effect OR 1.35; 95% CI 1.16–1.57; I²=7.1%; random-effects OR 1.34; 95% CI 1.13–1.59). For successful reperfusion (mTICI 2b–3), IVT+EVT also showed benefit (fixed-effect OR 1.50; 95% CI 1.19–1.89; I²=6.9%; random-effects OR 1.48; 95% CI 1.15–1.91). For symptomatic intracranial hemorrhage, no significant difference was observed between IVT+EVT and EVT alone (fixed-effect OR 0.97; 95% CI 0.71–1.33; random-effects OR 0.97; 95% CI 0.71–1.33; I²=0%). Prediction intervals confirmed robustness, and heterogeneity was low across all analyses. Publication bias was minimal, though trim-and-fill suggested up to 3 potentially missing studies for some outcomes.

Bridging therapy with IVT+EVT improves functional independence and reperfusion success without increasing hemorrhagic risk in tandem occlusions. These findings support IVT administration prior to EVT when not contraindicated.

Authors/Disclosures
Vishnu V. Byroju, MD (Cooper University Healthcare)
PRESENTER
Dr. Byroju has nothing to disclose.
Jamir Pitton Rissardo, MD Dr. Pitton Rissardo has nothing to disclose.
Arthur V. Gribachov, MD Dr. Gribachov has nothing to disclose.
Ana Leticia Fornari Caprara, MD Dr. Fornari Caprara has nothing to disclose.